A policy analysis of funding for ambitious interventional gerontology: The possibility of rejuvenation research at the National Institute on Aging

Rejuvenation Research

Volumn 7, Issue 3, 2004, Pages 211-222

  Mackey, Tom ^a  

^a GEORGETOWN UNIVERSITY LAW CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGING; BIOENGINEERING; GENE THERAPY; GERONTOLOGICAL RESEARCH; GERONTOLOGY; HEALTH CARE FINANCING; HEALTH CARE POLICY; INTERVENTIONAL GERONTOLOGY; LABORATORY; NATIONAL INSTITUTE ON AGING; ORGANIZATION; PRIORITY JOURNAL; REJUVENATION; REVIEW; TECHNOLOGY; TISSUE REPAIR;

AGED; AGING; GERIATRICS; HUMANS; NATIONAL INSTITUTES OF HEALTH (U.S.); POLICY MAKING; REJUVENATION; RESEARCH SUPPORT; UNITED STATES;

NIA;

EID: 6344275799     PISSN: 15491684     EISSN: None     Source Type: Journal    
DOI: 10.1089/rej.2004.7.211     Document Type: Review

References (33)

1. de Grey A. The foreseeability of real anti-aging medicine: focusing the debate. Exp Gerontol 2003;38: 927-934.
2. Rose M, Mueller L, Long A. Pharmacology, genomics, and the evolutionary biology of aging. Free Radic Res 2002;36:1293-1297.
3. Fossel M. Cells, Aging, and Human Disease. Oxford: Oxford University Press, 2003.
4. Gudkov A, Kazarov A, Thimmapaya R, et al. Cloning mammalian genes by expression selection of genetic suppressor elements: association of kinesin with drug resistance and cell immortalization. Proc Natl Acad Sci USA 1994;91:3744-3748.
5. Mombaerts P, Therapeutic cloning in the mouse. Proc Natl Acad Sci USA 2003;100(Suppl 1):11924-11925
6. Sherley J. Asymmetric cell kinetics genes: the key to expansion of adult stem cells in culture. Sci World J 2002;9:1906-1921.
7. de Grey A, Sprott R. How soon until we control aging? Transcript of debate between Aubrey de Grey and Richard Sprott, November 5, 2003. In: Sage Crossroads Staff (eds.): The Fight Over the Future. Lincoln, NE: iUniverse, 2004, pp. 163-208.
8. Hasty P, Vijg J. Accelerating aging by mouse reverse genetics: a rational approach to understanding longevity. Aging Cell 2004;3:55-65.
9. Miller R. Extending life: scientific prospects and political obstacles. Millbank Q 2002;80:155-174.
10. de Grey A, Baynes J, Berd D et al. Is human aging still mysterious enough to be left only to scientists? BioEssays 2002;24:667-676.
11. International Conference on Longevity. On-line. Available: www.longevity-international.com/ Registration%20Information.htm.
12. Lane, M, Ingram, D, Roth G. The serious search for an anti-aging pill. Sci Am 2002;287:36-41.
13. Shay/Wright Laboratory. Telomere/telomerase website [On-line]. Available: www..swmed.edu/homepages/cellbio/shay-wright.
14. News release. Geron reports positive data on GRN163L, a lipidated telomerase inhibitor drug for the treatment of cancer. November 20, 2003 [On-line]. Available: www.geron.com.
15. News release. Geron Corporation and Merix Bioscience, Inc. announce a co-exclusive license agreement for therapeutic cancer vaccines. March 10, 2004 [On-line]. Available: www.geron.com.
16. News release. Geron announces new data on GRN-163L, a telomerase inhibitor drug for cancer therapy. March 30, 2004 [On-line]. Available: www.geron.com.
17. News release. Geron announces publication of data on GRN163, a telomerase inhibitor, in animal models of human brain tumors. July 1, 2004 [On-line]. Available: www.geron.com.
18. Fossel M. Reversing Human Aging. New York: Morrow, 1996.
19. de Grey A. Outline proposal for an Institute of Biomedical Gerontology [On-line]. Available: www.gen. cam.ac.uk/sens/AdGpubs.htm.
20. Senate Appropriation Committee Report. FY 2004 budget for the National Institute on Aging [On-line]. Available: www.nia.nih.gov/fy2004_congress/ sig_items.htm.
21. Bioengineering nanotechnology initiative, July 2, 2002 [On-line]. Available: http://grants.nih.gov/grants/ guide/pa-files/PA-02-125.html.
22. Warner HR. E-mail correspondence with the author. January 22, 2004.
23. nd ed. Westbury, NY: Foundation, 1996.
24. Istook E, Porter J. Should disease prevalence determine NIH fund allocations? Physician's Weekly [On-line]. Available: www.faseb.org/opa/ newsletter/ oct98/10x98x3.html.
25. NIH. Aging interventions testing program, RFA: AG-02-005 [On-line]. Available: http://grants.nih.gov/ grants/guide/rfa-files/RFA-AG-02-005.html.
26. Gerontology Research Center [On-line]. Available: www.hia.nih.gov.
27. Ginis I, Rao MS. Toward cell replacement therapy: promises and caveats. Exp Neurol 2003;184:61-77.
28. Limke TL, Rao MS. Neural stem cell therapy in the aging brain: pitfalls and possibilities. J Hematother Stem Cell Res 2003;12:615-623.
29. Interagency Workshop on Research at the Interface of the Life Sciences and Physical Sciences [On-line]. Available: www.nibib.nih.gov/events/ interagency/.
30. Final Report. Interagency Workshop on Research at the Interface of the Life Sciences and Physical Sciences. National Institute of Biomedical Imaging and Bioengineering [On-line]. Available: www.nibib.nih. gov/events/interagency/ interagencyreport.pdf.
31. Bailine S. How ECT works. New York City Voices. 1998.
32. Pagnin D, de Queiroz V, Pini S, et al. Efficacy of ECT in depression: a meta-analytic review. J ECT 2004;20: 13-20.
33. Suzuki K, Awata S, Matsuoka H. One-year outcome after response to ECT in middle-aged and elderly patients with intractable catatonic schizophrenia. J ECT 2004;20:99-106.